RESOLVE to Make Cancer Screening a Priority
For 2022, let’s resolve to stay active with cancer screenings! According to the American Cancer Society more than 1.9 million
HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
We’re here for you. Call us at 844-346-7222 or
For 2022, let’s resolve to stay active with cancer screenings! According to the American Cancer Society more than 1.9 million
Lynnette Thompson had much to celebrate as she marked her 55th birthday in January 2020, including robust good health. “I
Pancreatic cancer has long been one of the most challenging cancers to treat successfully. That’s partly because most of its
“You look kind of yellow.” It was not the sort of dinner table conversation Brenda Morgart had anticipated when she
Uterine cancer is the most common cancer of the female reproductive system. It occurs most often in postmenopausal women in
Leading cancer care provider Regional Cancer Care Associates (RCCA) is proud to announce that it will be adding a new
Share on facebook Share on twitter Share on linkedin Share on email Share on print Patient-satisfaction ratings from the Oncology
Share on facebook Share on twitter Share on linkedin Share on email Share on print Doctors are at the forefront
Leukemia diagnoses are rising in northern New Jersey even as they fall nationwide, with Sussex and Morris counties outpacing the
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.